Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8216029 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 9 Pages |
Abstract
High residual metabolic activity in RLNs on post-treatment FDG-PET is associated with worse local-regional control. Based on these data, future trials evaluating a radiation therapy boost should consider inclusion of both primary tumor and FDG-avid RLNs in the boost volume to maximize local-regional control.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Stephanie MD, PhD, Fenghai PhD, Bradley S. MS, Barry A. MD, Mitchell MD, Jeffrey D. MD,